Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2016/0199357 METHODS FOR THE PRODUCTION OF FUNCTIONAL PROTEIN FROM DNA HAVING A NONSENSE MUTATION AND THE TREATMENT OF...
The present invention relates to functional proteins encoded by nucleic acid sequences comprising a nonsense mutation. The present invention also relates to...
2016/0199356 Cognition Enhancing Compounds and Compositions, Methods of Making, and Methods of Treating
The invention relates generally to muscarinic agonists, which are useful for stimulating muscarine receptors, and treating cognitive disorders. Included among...
2016/0199355 HEPATITIS C VIRUS INHIBITORS
The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit the function...
2016/0199354 METHODS FOR OLMESARTAN DOSING BY AUC
Methods for antihypertensive drug dosing by pharmacokinetic parameter determination. In one embodiment, the antihypertensive drug is olmesartan and the...
2016/0199353 3'-[(2Z)-[1-(3,4-DIMETHYLPHENYL)-1,5-DIHYDRO-3-METHYL-5-OXO-4H-PYRAZOL-4-Y- ...
Disclosed are novel pharmaceutical compositions containing 3'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-- ...
2016/0199352 PYRAZOLOANTHRONE AND DERIVATIVES THEREOF FOR TREATMENT OF CANCERS EXPRESSING MISSRII
The present invention relates to pyrazoloanthrones or functional derivatives or functional analogues thereof to activate MIS receptor-mediated downstream...
2016/0199351 COMPOSITIONS AND METHODS FOR INHIBITING FUNGAL INFECTIONS
Compositions and methods for inhibiting fungal growth by administering AR-12 to a host infected with a fungus such as Histoplasma capsulatum, Aspergillus...
2016/0199350 COMBINATION OF HDAC INHIBITORS WITH THROMBOCYTOPENIA DRUGS
The invention relates to a combination which comprises: (a) a HDAC inhibitor; and (b) an anti-thrombocytopenia drug, for simultaneous, concurrent, separate...
2016/0199349 Pharmaceutical Composition Comprising ...
The invention relates to a pharmaceutical composition comprising a first pharmacologically active ingredient, which is selected from ...
2016/0199348 Compounds
The present invention relates to compounds of formula (I): ##STR00001## wherein R.sup.1 and R.sup.2 are as defined herein. In certain embodiments, the compounds...
2016/0199347 METHODS FOR INHIBITING NATIVE AND PROMISCUOUS UPTAKE OF MONOAMINE NEUROTRANSMITTERS
The present invention relates to methods of inhibiting native and promiscuous uptake of biogenic amine neurotransmitters with triple reuptake inhibitors in the...
2016/0199346 CYCLIC NITRO COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF AND USES THEREOF
The present invention provides cyclic nitro compound, pharmaceutical compositions of cyclic nitro compounds and methods of using cyclic nitro compounds and/or...
2016/0199345 USE OF WILFORLIDE A FOR OVERCOMING CHEMOTHERAPY RESISTANCE
The invention provides compositions comprising wilforlide A for overcoming drug resistance in cancer therapy, particularly in the treatment of cancers which...
2016/0199344 METHODS FOR PURIFYING TRANS-(-)-.DELTA.9-TETRAHYDROCANNABINOL AND TRANS-(+)-.DELTA.9 TETRAHYDROCANNABINOL
Methods for making trans-(-)-.DELTA..sup.9-tetrahydrocannabinol and trans-(+)-.DELTA..sup.9-tetrahydrocannabinol are disclosed herein. In one embodiment, a...
2016/0199343 COMPOUNDS AND FORMULATIONS FOR THE TREATMENT OF WOUNDS
The present invention relates to the treatment of wounds. More particularly, it relates to compounds according to Formula (1) for use in methods of promoting...
2016/0199342 4-(PHENOXYALKYL)THIO)-PHENOXYACETIC ACIDS AND ANALOGS
The invention features 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs, compositions containing them, and methods of using them as PPAR delta modulators...
2016/0199341 BENZONATATE MODIFIED RELEASE SOLID TABLETS AND CAPSULES
A 12-hour anti-tussive modified release solid tablet or capsule is described which comprises a benzonatate adsorbate in a matrix with a sufficient amount of...
2016/0199340 CALEBIN A FOR HEPATIC STEATOSIS
The present invention discloses the potential of Calebin A in attenuating high fat diet (HFD) induced hepatic steatosis in mammals.
2016/0199339 COMPOSITION CONTAINING MONOACETYLDIACYLGLYCEROL COMPOUND AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING ASTHMA
The present invention relates to a pharmaceutical composition containing a monoacetyldiacylglycerol compound as an active ingredient for preventing or treating...
2016/0199338 COMPOSITIONS CONTAINING MONOACETYLDIACYLGLYCEROL COMPOUND AS AN ACTIVE INGREDIENT FOR PREVENTING OR TREATING...
The invention relates to pharmaceutical compositions, as well as health functional food compositions and quasi-drug compositions, for preventing, treating, or...
2016/0199337 Nutritional Formulas Comprising Medium Chain Fatty Acids or Esters Thereof and Methods Related Thereto
This disclosure relates to nutritional formulas and uses for treating or preventing a gastrointestinal condition and/or motor-planning speech and/or...
2016/0199336 CONTROLLED RELEASE FUMARATE ESTERS
Described herein are pharmaceutical compositions comprising fumarate esters, methods for making the same, and methods for treating subjects in need thereof. In...
2016/0199335 CONTROLLED RELEASE FUMARATE ESTERS
Described herein are pharmaceutical compositions comprising fumarate esters, methods for making the same, and methods for treating subjects in need thereof. In...
2016/0199334 METHODS OF THERAPEUTIC MONITORING OF NITROGEN SCAVENGING DRUGS
The present disclosure provides methods for evaluating daily ammonia exposure based on a single fasting ammonia blood level measurement, as well as methods...
2016/0199333 METHODS OF THERAPEUTIC MONITORING OF NITROGEN SCAVENGING DRUGS
The present disclosure provides methods for evaluating daily ammonia exposure based on a single fasting ammonia blood level measurement, as well as methods...
2016/0199332 METHODS OF THERAPEUTIC MONITORING OF NITROGEN SCAVENGING DRUGS
The present disclosure provides methods for evaluating daily ammonia exposure based on a single fasting ammonia blood level measurement, as well as methods...
2016/0199331 INFANT NUTRITION WITH LIPID GLOBULES TO INCREASE ENERGY EXPENDITURE AND METABOLIC FLEXIBILITY LATER IN LIFE
The present invention relates to nutrition for infants and young children with particular lipid globules, resulting in programming the metabolism to an...
2016/0199330 ANILINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
The present invention relates to therapeutic applications of aniline derivatives of formula (I), for example in treating glaucoma: Formula (I), R1a represents...
2016/0199329 BROAD SPECTRUM PHARMACOLOGICAL COMPOSITION FOR TREATMENTOF VARIOUS INFECTIONS AND DISEASES AND METHODSOF USE
A pharmacological composition for the treatment of bacterial and protozoal infections in a patient. The preferred pharmacological composition comprises a...
2016/0199328 INTERMEDIATE METABOLISM PRODUCTS TO POTENTIATE AMINOGLYCOSIDE ANTIBIOTICS IN BACTERIAL INFECTIONS
Provided herein are compositions and methods to improve treatment of chronic infections, and reduce, delay, or inhibit formation of biofilms, using specific...
2016/0199327 Solid Solution Compositions and Use in Chronic Inflammation
The present specification discloses pharmaceutical compositions, methods of preparing such pharmaceutical compositions, and methods and uses of treating a...
2016/0199326 USE OF TRIFLUOROACETIC ACID AS KERATOLYTIC AGENT TO TREAT HYPERKERATOTIC SKIN LESIONS
The present invention is directed to the use of Trifluoroacetic acid and its physiologically acceptable salts as keratolytic agent to treat skin lesions...
2016/0199325 INJECTABLE LIQUID PARACETAMOL FORMULATION
The invention relates to an aqueous paracetamol solution for its use by perfusion with a pH between 4.5 and 6.0, comprising at least one substance that can...
2016/0199324 MULTIPLE MYELOMA TREATMENT
The invention relates generally to the treatment of multiple myeloma. One embodiment of the invention provides a method of treating multiple myeloma (MM) in an...
2016/0199323 CANCER TREATMENT
The invention relates generally to the treatment of cancer. One embodiment of the invention provides a method of treating cancer in an individual, the method...
2016/0199322 WOUND TREATMENT EMPLOYING ANTIMICROBIAL COMPOSITION
An aqueous composition with a higher-than-neutral pH includes a significant amount of one or more surfactants and large amounts of osmotically active solutes....
2016/0199321 BUPROPION AS A MODULATOR OF DRUG ACTIVITY
Dosage forms, drug delivery systems, and methods related to sustained release of dextromethorphan or improved therapeutic effects are disclosed. Typically,...
2016/0199320 Ophthalmic Treatments
Aqueous compositions suitable for topical administration to the human or animal eye contain at least one water-soluble polymeric ophthalmic lubricant, such as...
2016/0199319 Intestinal flora improving composition containing astaxanthin and its use
An oral composition that improves intestinal flora via oral intake includes astaxanthin as an active ingredient, and excludes a component that can form skin...
2016/0199318 Anti-Viral Compound and Composition
A use of polygodial or a structural derivative thereof, or a plant extract containing polygodial or a structural derivative thereof for the manufacture of a...
2016/0199317 ESTRADIOL CONTAINING TRANSDERMAL DRUG DELIVERY SYSTEMS AND COMPOSITIONS
Transdermal drug delivery systems and compositions containing estradiol. The systems and compositions can include levulinic acid in an amount to enhance...
2016/0199316 THREE-LAYER TRANSDERMAL THERAPY SYSTEM (TTS)
The invention relates to an at least three-layer transdermal therapy system (TTS), which contains, in particular, rotigotine as an active ingredient. The TTS...
2016/0199315 ADHESIVE PATCH
The present invention is a patch comprising a support, and an adhesive layer disposed on at least one surface of the support and formed of an adhesive...
2016/0199314 TOPICAL DRUG PATCH INCLUDING MICROSPHERES
A topical drug delivery patch (1) comprising a drug delivery layer (3) including microspheres (2) encapsulating a drug, said microspheres being carried in a...
2016/0199313 TRANSDERMAL PATCH
A transdermal patch includes a protective layer, a matrix layer, an adhesive layer, and a cover layer. The cover layer is at least partially bi-elastic, and...
2016/0199312 Compositions for Treatment of Attention Deficit Hyperactivity Disorder
Therapeutic compositions and methods for treatment of attention deficit disorder (ADD) or attention deficit hyperactivity disorder (ADHD) and other CNS...
2016/0199311 SEMI-PERMEABLE ENCAPSULATION SYSTEM WITH TAPERED CONDUITS FOR DIABETES REVERSAL
Some embodiments of the present disclosure include an encapsulated islet for treating diabetes. The encapsulated islet may include a semi-permeable capsular...
2016/0199310 Novel 2,4-Dinitrophenol Formulations and Methods Using Same
The present invention includes a low dose and sustained release formulation of 2,4-dinitrophenol (DNP). The compositions of the invention are useful for...
2016/0199309 NANOPARTICLE AND POLYMER FORMULATIONS FOR THYROID HORMONE ANALOGS, ANTAGONISTS, AND FORMULATIONS AND USES THEREOF
Disclosed are methods of treating subjects having conditions related to angiogenesis including administering an effective amount of a polymeric nanoparticle...
2016/0199308 MAGNETIC NANO CORE-SHELL CAPSULE AND APPLICATION THEREOF
The present invention provides a magnetic nano core-shell capsule for drug delivery, which including: a plurality of amphiphilic protein, a plurality of iron...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.